Objectives To examine if therapeutic hypothermia reduces the composite outcome of death, moderate or severe disability at 18 months or more after mild neonatal encephalopathy (NE).
Data source MEDLINE, Cochrane database, Scopus and ISI Web of Knowledge databases, using ‘hypoxic ischaemic encephalopathy’, ‘newborn’ and ‘hypothermia’, and ‘clinical trials’ as medical subject headings and terms. Manual search of the reference lists of all eligible articles and major review articles and additional data from the corresponding authors of selected articles.
Study selection Randomised and quasirandomised controlled trials comparing therapeutic hypothermia with usual care.
Data extraction Safety and efficacy data extracted independently by two reviewers and analysed.
Results We included the data on 117 babies with mild NE inadvertently recruited to five cooling trials (two whole-body cooling and three selective head cooling) of moderate and severe NE, in the meta-analysis. Adverse outcomes occurred in 11/56 (19.6%) of the cooled babies and 12/61 (19.7%) of the usual care babies (risk ratio 1.11 (95% CIs 0.55 to 2.25)).
Conclusions Current evidence is insufficient to recommend routine therapeutic hypothermia for babies with mild encephalopathy and significant benefits or harm cannot be excluded.
- hypoxic ischaemic encephalopathy
- therapeutic hypothermia
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Contributors UK searched the literature, extracted the data and drafted the manuscript along with PM and PJL. RP and TM extracted the data and examined the study quality with NL. JT searched the literature. VO, AS and SS interpreted the data and assisted in developing the manuscript. ST conceived the idea, performed the meta-analysis and supervised the entire work.
Funding PM is funded by an MRC doctoral fellowship, VO by an NIHR doctoral fellowship and PJL by an NIHR clinical trials fellowship. This research was supported by the NIHR Biomedical Research Centre based at Imperial College London.
Disclaimer The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health.
Competing interests None declared.
Provenance and peer review Not commissioned; externally peer reviewed.
Patient consent for publication Not required.